glp-1 kidney function Glucagon-like peptide 1(GLP-1) receptor agonists in the management of the patient with type 2diabetes mellitus and chronic disease: an approach for the nephrologist GLP-1 Receptor Agonists and Diabetic
Description
ihealthunifiedcare.com/articles/manag #GLP1 #iHealth #UnifiedCare

Body Composition: Healthy participants experienced reductions in body fat percentage and tricipital skinfold ( p = 0.001), despite no changes in total body weight or body circumferences

Dietary supplementation with vitamin D stimulates intestinal epithelial cell turnover after massive small bowel resection in rats

During your first week, you may experience mild side effects, such as nausea or gastrointestinal discomfort

Several large-scale RCTs and meta-analyses have reported no statistically significant increase in pancreatitis risk associated with GLP-1 RAs

As researchers are also investigating semaglutide as a treatment for substance use disorderswhich often co-occur with other mental health disordersit is vital to ensure the medication is safe and does not place vulnerable groups at even greater risk of harmful health impacts. The authors recommend that future studies look at associations between semaglutide and suicidal thoughts over longer periods of time
